Lexaria Bioscience (LEXX) Amortization of Goodwill (2023 - 2024)
Lexaria Bioscience's (LEXX) quarterly Amortization of Goodwill came in at $34329.0 in Q2 2024, down 67.84% quarter-over-quarter from $106761.0 in Q3 2023.
Lexaria Bioscience (LEXX) Amortization of Goodwill (2023 - 2024) Analysis & Trends
Lexaria Bioscience has disclosed Amortization of Goodwill across 2 years of filings, most recently posting $34329.0 for Q2 2024.
- Amortization of Goodwill for Q2 2024 came in at $34329.0, changed N/A year-over-year; the trailing twelve-month figure through Aug 2024 was $141090.0 (changed N/A YoY), and the FY2024 annual result was $57836.0, down 45.83% from the prior year.
- Amortization of Goodwill came in at $34329.0 for Q2 2024 at Lexaria Bioscience, down from $106761.0 in the prior quarter.
- In the past five years, Amortization of Goodwill ranged from a high of $106761.0 in Q3 2023 to a low of $34329.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Lexaria Bioscience | 7.17 Mn | 1.65 Mn | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | 34,329.00 |
| May 31, 2024 | 34,329.00 |
| Aug 31, 2023 | 106,761.00 |
| Aug 31, 2023 | 106,761.00 |